Announcements Trials
Browse Landscape

Phase

Phase 1 21Phase 2 15Phase 1/2 11Phase 3 5Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 6Colorectal Neoplasms 5Pancreatic Neoplasms 4Neoplasms 4Glioma 4Sarcoma 3Prostatic Neoplasms 3Neoplasm Metastasis 3Melanoma 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Pancreatic Ductal Adenocarcinoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Immunoglobulin Light-chain Amyloidosis 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Basal Cell 2Burkitt Lymphoma 2Advanced Solid Tumors 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Skin Neoplasms 1Sarcoma, Ewing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Triple Negative Breast Neoplasms × 30 days × Clear all
NCT04861077 2026-06-02

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

University of Alabama at Birmingham

Phase EARLY_PHASE1 Recruiting
20 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡